These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 31424187)
1. Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson's Disease Cui W; Zhan Y; Shao X; Fu W; Xiao D; Zhu J; Qin X; Zhang T; Zhang M; Zhou Y; Lin Y ACS Appl Mater Interfaces; 2019 Sep; 11(36):32787-32797. PubMed ID: 31424187 [TBL] [Abstract][Full Text] [Related]
2. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model. Gu PS; Moon M; Choi JG; Oh MS J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433 [TBL] [Abstract][Full Text] [Related]
3. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease. Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304 [TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model. Li H; Park G; Bae N; Kim J; Oh MS; Yang HO J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways. Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease. Hacioglu G; Seval-Celik Y; Tanriover G; Ozsoy O; Saka-Topcuoglu E; Balkan S; Agar A Folia Histochem Cytobiol; 2012 Jul; 50(2):228-38. PubMed ID: 22763967 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. Zhang L; Huang L; Chen L; Hao D; Chen J Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879 [TBL] [Abstract][Full Text] [Related]
9. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease. Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo. Doo AR; Kim SN; Park JY; Cho KH; Hong J; Eun-Kyung K; Moon SK; Jung WS; Lee H; Jung JH; Park HJ J Ethnopharmacol; 2010 Sep; 131(2):433-42. PubMed ID: 20633628 [TBL] [Abstract][Full Text] [Related]
11. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Liu Z; Yu Y; Li X; Ross CA; Smith WW Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra. Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869 [TBL] [Abstract][Full Text] [Related]
13. Baicalin Represses C/EBP Lei K; Shen Y; He Y; Zhang L; Zhang J; Tong W; Xu Y; Jin L Oxid Med Cell Longev; 2020; 2020():8951907. PubMed ID: 32566108 [TBL] [Abstract][Full Text] [Related]
14. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway. Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717 [TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease. Chen Y; Zhang Y; Li L; Hölscher C Eur J Pharmacol; 2015 Dec; 768():21-7. PubMed ID: 26409043 [TBL] [Abstract][Full Text] [Related]
18. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions. Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice. Prema A; Janakiraman U; Manivasagam T; Thenmozhi AJ Neurosci Lett; 2015 Jul; 599():12-9. PubMed ID: 25980996 [TBL] [Abstract][Full Text] [Related]
20. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. Mandel S; Maor G; Youdim MB J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]